Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023–2024
- 4 April 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (4) , e172-e183
Abstract
Background: We describe prescribing and dispensing patterns of influenza antivirals among patients with laboratory-confirmed influenza within US urgent care and emergency department settings. Methods: A retrospective cross-sectional study was conducted for encounters from 4 large, integrated health systems participating in the VIrtual Sars-cov-2, Influenza, and Other respiratory viruses Network (VISION) of adult patients presenting with acute respiratory illness to urgent care or emergency departments and with positive influenza virus test results during the 2023–2024 influenza season. The analysis was restricted to adult patients at higher risk of influenza complications based on presence of underlying medical conditions, older age, pregnancy, and severe obesity. We calculated proportions and odds of prescribed and dispensed antivirals by demographic and clinical characteristics. Results: A total of 10 700 patient encounters were eligible for analysis. Among encounters with a positive standard molecular influenza test result (n = 5231), 58% (range across sites: 47%–64%) were prescribed antivirals, with 67% of prescribing occurring on the encounter date. Among those prescribed antivirals (n = 3050), 80% (range across sites: 75%–91%) had them dispensed, with 65% of dispensing occurring on the prescription date. Encounters among persons aged ≥65 years had lower odds of same-day prescribing (.57; 95% CI: .42–.78) and lower odds of same-day dispensing (.58; 95% CI: .36–.94) compared with those aged 18–49 years. Conclusions: Gaps in antiviral treatment within urgent care and emergency department settings remain for patients at higher risk of influenza complications, notably among older adults. Strategies to improve earlier initiation of antiviral treatment may help reduce the risk of influenza-associated complications.Keywords
Funding Information
- Centers for Disease Control and Prevention (CDC; (75D30121D12779, 75D30123C17595, 75D30123C18039)
- Kaiser Foundation Hospitals
This publication has 42 references indexed in Scilit:
- Prescription Medication Use Among Older Adults in the USJAMA Internal Medicine, 2024
- Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With InfluenzaJAMA Internal Medicine, 2024
- Cost-Related Medication Nonadherence and Desire for Medication Cost Information Among Adults Aged 65 Years and Older in the US in 2022JAMA Network Open, 2023
- Disparities in Access and Quality of Obesity CareGastroenterology Clinics of North America, 2023
- A model of weight‐based stigma in health care and utilization outcomes: Evidence from the learning health systems networkObesity Science & Practice, 2021
- Addressing Influenza Vaccination Disparities During the COVID-19 PandemicJAMA, 2020
- The impact of continuity of care on antibiotic prescribing in acute otitis mediaInternational Journal of Pediatric Otorhinolaryngology, 2019
- Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenzaDiagnostic Microbiology and Infectious Disease, 2017
- Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in healthJournal of Clinical Epidemiology, 2014
- Impact of Rapid Diagnosis on Management of Adults Hospitalized With InfluenzaArchives of internal medicine (1960), 2007